Home / Community / News / News

News

12/01/2016 - 10:56am

Scientists from a consulting firm with considerable experience in evaluation of patient-reported outcome measures evaluated available PROMs for their potential in DM1 clinical trials.

09/22/2016 - 11:46am

New studies in mouse models show that constitutive or acquired loss of Dmpk has no effects on skeletal or cardiac muscle function.

09/22/2016 - 11:24am

A recent study corroborated increased susceptibility to cancer in DM1, for women in particular, and linked the elevated risk to depressed levels of a tumor suppressor microRNA (miRNA). 

08/19/2016 - 3:15pm

Acclaimed musician Eric Hutchinson is using his new album to support Care and a Cure. Read his inspiring family story.

08/10/2016 - 12:42pm

AMO Pharma Limited (AMO Pharma) today announced initiation of a phase 2 clinical study in the U.K. for AMO-02 (tideglusib).

Partners

© Myotonic Dystrophy Foundation. All rights reserved.